Novartis AG (NOVN.S)
21 Sep 2018
ZURICH, Sept 21 A European Medicines Agency panel recommended approval of Spark Therapeutics' gene therapy for blindness, a move that also boosts Swiss drugmaker Novartis that bought the rights to one of the world's costliest treatments outside the United States.
LONDON, Sept 19 Health authorities in England have rejected a pricey CAR-T cell therapy from Novartis for adults with blood cancer, two weeks after endorsing its use in children and young people.
ZURICH, Sept 17 Swiss drugmaker Novartis has revealed its employees only get a bonus if they meet or exceed expectations for ethical behaviour as it seeks to address past shortcomings that have damaged its reputation.
ZURICH/BERLIN, Sept 17 The Swiss blue-chip SMI was seen opening 0.1 percent lower at 8,965 points on Monday, according to premarket indications by bank Julius Baer .
ZURICH The headquarters of Alcon, the eyecare unit of Novartis which will be spun off to shareholders in 2019, will move from the division's longtime corporate home in the Dallas suburbs to the Swiss city of Geneva, Novartis said in a statement on Tuesday.
* Texas to remain major site for eyecare unit post spin-off (Adds detail about headquarters in Geneva, comment from CEO)
ZURICH, Sept 11 Alcon, the eyecare unit of Novartis set to be spun off into a separate company next year, plans to have its headquarters in Geneva, saying the location will help increase the business's global scale.
ZURICH/BERLIN, Sept 10 The Swiss blue-chip SMI was seen opening 0.2 percent higher at 8,862 points on Monday, according to premarket indications by bank Julius Baer .
ZURICH/BERLIN, Sept 7 Here are some of the main factors that may affect Swiss stocks on Friday:
ZURICH/BENGALURU New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is selling U.S. dermatology and generic pill assets to India's Aurobindo Pharma Ltd for up to $1 billion.